PLIANT THERAPEUTICS, INC. — Director's Dealing 2021

Mar 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLIANT THERAPEUTICS, INC. (PLRX)
CIK: 0001746473
Period of Report: 2021-03-05

Reporting Person: Cummings Keith Lamont (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-05	Common Stock	M	20000	$2.08	Acquired	47621	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-05	Stock Option (right to buy)	$2.08	M	20000	Disposed	2029-01-23	Common Stock (20000)	Direct

Footnotes

F1: 25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.